Image

Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to demonstrate the added value of mobile health (mHealth) to detect atrial fibrillation (AF) early in the care path of cryptogenic stroke and transient ischemic attack (TIA) patients.

Description

The use of photoplethysmography (PPG)-based mHealth (with smartphone and smartwatch) is compared to the guideline-recommended insertable loop recorders (ILR) in the detection of AF in cryptogenic stroke or TIA patients.

Eligibility

Inclusion Criteria:

  • Diagnosis of cryptogenic ischemic stroke or TIA
  • The patient or its legal representative is willing to sign the informed consent

Exclusion Criteria:

  • History of AF or atrial flutter
  • Life expectancy of less than one year
  • Not qualified for ILR insertion
  • Indication or contraindication for permanent oral anticoagulants (OAC) at enrolment
  • Untreated hyperthyroidism
  • Myocardial infarction or coronary bypass grafting less than one month before the stroke onset
  • Presence of patent foramen ovale (PFO) and it is or was an indication to start OAC according to the European Stroke Organization guidelines
  • Inclusion in another clinical trial that will affect the objectives of this study
  • Not able to understand the Dutch language
  • Patient or partner not in possession of a smartphone

Study details

Cryptogenic Stroke, Atrial Fibrillation

NCT05006105

Ziekenhuis Oost-Limburg

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.